James Patrick Allison

122.7k citations
494 papers · 100.8k · 54 hit papers · h-index 149

Impact in

  • Immunology top 0.01%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immune cells in cancer
  • Oncology top 0.01%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immunotherapy and Immune Responses 187
    • Immune Cell Function and Interaction 172
    • T-cell and B-cell Immunology 154
    • Cancer Immunotherapy and Biomarkers 172
    • CAR-T cell therapy research 87

James Patrick Allison

487 papers receiving 98.2k citations

James Patrick Allison's Hit Papers

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy 2025 · 33 citations
330+2+5Years since publication50010001.5k2.0k2.5k

Peers

James Patrick Allison
Comparison fields: 5 of 195
  • Immunology 56.9k
  • Oncology 51.8k
  • Biological Psychiatry 942
  • Cancer Research 5.2k
  • Molecular Biology 19.7k
Replace Robert D. Schreiber with:
Robert D. Schreiber United States
Mark John Smyth Australia
Gordon James Freeman United States
Arlene H. Sharpe United States
Lieping Chen United States
Drew Pardoll United States
Lloyd J. Old United States
Suzanne Louise Topalian United States
Frank Stephen Hodi United States
Reinhard Dummer Switzerland
James Patrick Allison relative to Robert D. Schreiber United States Robert D. Schreiber's profile →
Citations per field
00.5×1.5×1.9×
Robert D. Schreiber · 1×
Citations per year

Countries citing papers authored by James Patrick Allison

Since Specialization
Citations

This map shows the geographic impact of James Patrick Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Patrick Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Patrick Allison more than expected).

Fields of papers citing papers by James Patrick Allison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Patrick Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Patrick Allison. The network helps show where James Patrick Allison may publish in the future.

Co-authors

The 25 scholars most cited alongside James Patrick Allison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Patrick Allison Line = papers co-authored together James Patrick Allison links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 494 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The future of immune checkpoint therapy
Hit paper breakdown →
20154008
2
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Hit paper breakdown →
20173810
3
Restoring function in exhausted CD8 T cells during chronic viral infection
Hit paper breakdown →
20053369
4
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Hit paper breakdown →
19963233
5
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Hit paper breakdown →
20182506
6
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Hit paper breakdown →
20142187
7
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Hit paper breakdown →
20151947
8
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Hit paper breakdown →
19951864
9
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Hit paper breakdown →
20121774
10
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Hit paper breakdown →
20141703
11
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Hit paper breakdown →
20101601
12
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
Hit paper breakdown →
19921406
13
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
Hit paper breakdown →
20031355
14
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
Hit paper breakdown →
20131237
15
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Hit paper breakdown →
20091177
16
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Hit paper breakdown →
20171077
17
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Hit paper breakdown →
20161075
18
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hit paper breakdown →
20121047
19
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
Hit paper breakdown →
19931033
20
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Hit paper breakdown →
2016902

About James Patrick Allison

James Patrick Allison is a scholar working on Immunology, Oncology, Developmental and Educational Psychology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 494 papers that have together received 100.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (187 papers), Immune Cell Function and Interaction (172 papers), Cancer Immunotherapy and Biomarkers (172 papers), T-cell and B-cell Immunology (154 papers), CAR-T cell therapy research (87 papers), Monoclonal and Polyclonal Antibodies Research (36 papers), Behavioral and Psychological Studies (29 papers) and Diabetes and associated disorders (24 papers). The work is most often cited by research in Immunology (56.9k citations), Oncology (51.8k citations), Biological Psychiatry (942 citations), Cancer Research (5.2k citations) and Molecular Biology (19.7k citations). James Patrick Allison has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Padmanee Sharma, Matthew F. Krummel, Dana R. Leach, Cynthia A. Chambers, Spencer C. Wei, Karl S. Peggs, Jedd D. Wolchok, Colm R. Duffy, Jackson G. Egen and Wendy L. Havran. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Nature and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

You can learn more about the impact of James Patrick Allison by visiting their Pantheon page.

Explore authors with similar magnitude of impact